Community health workers may boost home dialysis use in High-Risk patients
NCT ID NCT06925776
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adding a community health worker to a kidney care team helps more patients with advanced kidney disease choose or start home dialysis. About 106 adults with severe chronic kidney disease will be split into two groups: one gets standard team care, the other gets the same plus a community health worker. Researchers will track home dialysis rates, patient engagement, and social needs over one year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 106 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2025
- Expected to finish
-
May 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years * Advanced CKD (defined by estimated glomerular filtration rate (eGFR) of 25 ml/min/1.73m2 or less using the 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation) * English or Spanish speaking * Provide informed consent * Followed by a nephrologist at Montefiore and seen within last 12 months * Willing to receive interdisciplinary care (i.e., nurse practitioner facilitated CKD education and care coordination) Exclusion Criteria: * Active malignancy * Anticipated survival is less than 1 year as determined by the patient's treating nephrologist * Opting to do medical management only (non- dialysis supportive care) for management of their kidney failure * Plan to relocate outside of New York City within the next 12 months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic kidney disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Albert Einstein College of Medicine
RECRUITINGThe Bronx, New York, 10461, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a breathing workout and walks help dialysis patients with irregular heartbeats?
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Can a Patient's own kidney cells hold off dialysis?
- A blood test at 50 could flag your risk of five diseases. can an app stop them?
- Two drugs, one goal: can finerenone or semaglutide cut kidney damage markers?
- One team, three conditions: can coordinated care tame heart, kidney, and diabetes?